NASDAQ$BTTC

Black Titan Corp · Q1 2013 earnings

Q1 2013 earnings · Reported Mar 31, 2013 (13 years ago) · Investor relations

Mar 31Mar 31, 2013

Total Revenue

$5.17M

Previous: $1.27M+307.4%

EPS (adj)

$2.40

Previous: -$2.70+188.9%

Capital Expenditures

$180K

Previous: $522K-65.5%

Free Cash Flow

-$1.88M

Previous: -$3.05M+38.3%

Net Income

$6M

Previous: -$5.16M+216.2%

Operating Income

$171K

Previous: -$3.53M+104.8%

Gross Profit

$1.26M

Previous: $1.27M-0.6%

Cash & Equivalents

$17.6M

Previous: $2.31M+662.8%

Total Assets

$23.5M

Previous: $7.51M+213.4%

Stock-Based Comp

$505K

Previous: $1.55M-67.5%

Titan Pharmaceuticals · Revenue · Quarterly

$5.17M

Q1 2013+307.4%vs Q1 2012

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation